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a b s t r a c t
The tobacco-speciﬁc nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) is a potent
human carcinogen. Metabolic activation of NNK generates a number of DNA adducts including
O2-methylthymidine (O2-Me-dT) andO2-[4-(3-pyridyl)-4-oxobut-1-yl]thymidine (O2-POB-dT). To inves-
tigate the biological effects of these O2-alkylthymidines in humans, we have replicated plasmids
containing a site-speciﬁcally incorporated O2-Me-dT or O2-POB-dT in human embryonic kidney 293T
(HEK293T) cells. The bulkier O2-POB-dT exhibited high genotoxicity and only 26% translesion synthesis
(TLS) occurred, while O2-Me-dT was less genotoxic and allowed 55% TLS. However, O2-Me-dT was 20%
more mutagenic (mutation frequency (MF) 64%) compared to O2-POB-dT (MF 53%) in HEK293T cells. The
major type of mutations in each case was targeted T→A transversions (56% and 47%, respectively, for
O2-Me-dT and O2-POB-dT). Both lesions induced a much lower frequency of T→G, the dominant muta-
tion in bacteria. siRNA knockdown of the TLS polymerases (pols) indicated that pol , pol , and Rev1 are
involved in the lesion bypass of O2-Me-dT and O2-POB-dT as the TLS efﬁciency decreased with knock-
2iRNA knockdown
down of each pol. In contrast, MF of O -Me-dT was decreased in pol  and Rev1 knockdown cells by 24%
and 25%, respectively, while for O2-POB-dT, it was decreased by 44% in pol  knockdown cells, indicating
that these TLS pols are critical for mutagenesis. Additional decrease in both TLS efﬁciency and MF was
observed in cells deﬁcient in pol  plus other Y-family pols. This study provided important mechanistic
details on how these lesions are bypassed in human cells in both error-free and error-prone manner.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).. IntroductionTobacco use is the single largest preventable cause of disease
nd premature death in the US, yet more than 45 million Amer-
Abbreviations: NNK, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone; NNN,
’-nitrosonornicotine; O2-Me-dT, O2-methylthymidine; O2-POB-dT, O2-[4-(3-
yridyl)-4-oxobut-1-yl]thymidine; HEK293T, human embryonic kidney 293T; TLS,
ranslesion synthesis; MF, mutation frequency; pol, DNA polymerase; Kf-, exo-free
lenow fragment of DNA polymerase I; Dpo4, Sulfolobus solfactaricus DNA poly-
erase IV.
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/).icans still smoke cigarettes. Tobacco products contain over 5000
compounds and over 70 carcinogens [1]. Amongst the plethora of
carcinogens present in tobacco and tobacco smoke, likely candi-
dates for initiating cancers are the tobacco-speciﬁc nitrosamines,
including4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)
and N’-nitrosonornicotine (NNN) [2–5]. Intermediates formed dur-
ing metabolic activation of these compounds by P450 have been
shown to covalently bind to DNA forming DNA adducts [6]. NNK
thus far is theonly carcinogen found in tobaccoproducts that causes
lung tumors in animal models, irrespective of the route of admin-
istration [7,8].
NNK can be metabolically activated to generate methylat-
ing agents or to generate pyridyloxobutyalting agents [6,7].
These agents react with DNA forming methyl (Me) and 4-
(3-pyridyl)-4-oxobutyl (POB) adducts, respectively. The most
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
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ommon methylated DNA adducts identiﬁed in NNK-treated
odents formed in the methylation pathway are 7-Me-dG and
6-Me-dG [9–11]; however, other methylation products such as
2-Me-dC and O2-Me-dT are also most likely formed [9]. While
utagenicity and carcinogenicity of the methylation pathway of
NK-derived O6-Me-dG and its link to carcinogenesis is well doc-
mented [8,10–14], the relative importance of the POB-pathway is
till under investigation.
The pyridyloxobutylating pathway generates four POB
dducts including O2-POB-dT, O2-POB-dC, O6-POB-dG and
-POB-dG, which were detected in NNK treated rats and
ice [15–17]. A/J mice treated with a pyridyloxobutylating
gent, 4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone
NNKOAc), showed that three POB DNA adducts, O2-POB-dT, O6-
OB-dG and 7-POB-dG, form and persist in lung DNA at signiﬁcant
evels, suggesting their likely involvement in lung carcinogenesis
18]. However, O2-POB-dT was identiﬁed as the most abundant
OB adduct in lung tissues of A/J female mice [19] as well as
he most persistent adduct in lung and liver of male F344 rats
reated with NNK [20]. NNKOAc-treated CHO cells produced point
utations mainly at the AT base pairs, implicating O2-POB-dT as a
andidate lesion responsible for these mutation [21].
In vivo mutagenesis study of O2-Me-dT and O2-POB-dT (struc-
ures shown in Plate 1) showed that these DNA lesions are
ighly mutagenic in Escherichia coli cells [22]. Both survival and
he mutagenicity were increased with SOS induction, suggesting
nvolvement of bacterial TLS pols for their bypass andmutagenesis.
eplicationofO2-alkylthymidine lesionswithvaryingsidechains in
. coli showed that bypass efﬁciency decreased as the chain length
f the alkyl group increased [23] and pol V is indispensable for
→A mutations [22]. In vitro kinetics using exo-free Klenow frag-
ent of E. coli DNA polymerase I (Kf−), Sulfolobus solfactaricus DNA
olymerase IV (Dpo4), human polymerase  (pol ) and yeast poly-
erase eta (pol ) established that O2-Me-dT is a strong block to
NA synthesis and that the correct nucleotide dATP is preferen-
ially incorporated opposite O2-Me-dT [24,25]. Likewise, bypass of
2-POB-dT is inefﬁcient by Kf− and Dpo4, but, when bypass occurs,
he wrong nucleotide dTTP is preferentially incorporated opposite
2-POB-dT [25].
To test the hypothesis that O2-POB-dT, the most abundant
NA adduct of the POB-pathway of NNK, is mutagenic, we have
ransfected a single-stranded (ss) pMS2 plasmid containing a sin-
le O2-Me-dT or O2-POB-dT in human embryonic kidney 293T
ells (HEK293T). In addition, we investigated the involvement of
LS pols, including pol , , ,  and Rev1, for lesion bypass and
utagenesis by siRNA-induced knockdown of these TLS pols. We
etermined that both O2-Me-dT and O2-POB-dT are highly muta-
enic in human cells, inducing predominantly T→Amutations.We
lso found that the lesion bypass is dependent on pol , , and Rev1.
. Materials and methods
.1. Materials
[-32P]ATP was purchased from Du Pont New England Nuclear
Boston, MA). All enzymes, including EcoRV restriction endonu-
lease, T4 DNA ligase, T4 polynucleotide kinase, uracil DNA
lycosylase, and exonuclease III, were obtained from New England
ioloabs (Beverly, MA). HEK293T cells were purchased from the
merican Type Culture Collection (Manassas, VA). E. coli DH10B
ells was purchased form Life Technologies, Inc. (Grand Island, NY)siRNAs: Synthetic siRNA duplexes against POLH (SI02663619),
OLK (SI04930884), POLI (SI03033310), REV1 (SI00115311), and
ll Stars negative control siRNA (1027280) were purchased from
iagen (Valencia, CA). The siRNA forREV3waspurchased from Inte-epair 35 (2015) 63–70
grated DNA Technologies (Coralville, IA). Sequences of the siRNAs
are listed in Table S1 of the Supporting information.
2.2. Synthesis and characterization of oligonucleotides
The modiﬁed oligonucleotides 5′-GTGCGT*GTTTGT-3′, (where
T* represents O2-Me-dT or O2-POB-dT) containing the DNA
sequence of p53 codons 272–275 in which the lesion was located
in codon 273, were synthesized and characterized as reported [22].
Oligonucleotides were analyzed by MALDI-TOF MS analysis, which
gave a molecular ion with a mass within 0.005% of theoretical. The
M+1 for theO2-Me-dT oligodeoxynucleotide is 3713 andwe found
an m/z of 3712. The M+1 for the O2-POB-dT oligodeoxynucleotide
is 3846 and we found an m/z of 3847. Unmodiﬁed oligonucleotides
were analyzed by MALDI-TOF MS analysis, which gave a molecular
ion with a mass within 0.005% of theoretical.
2.3. Construction and characterization of pMS2 vectors
containing a single O2-Me-dT or O2-POB-dT
The single-stranded (ss) pMS2 shuttle vector, which contains
its only EcoRV site in a hairpin region was prepared as described
[26]. Synthesis and characterization of the lesion-containing and
control constructs followed a protocol reported earlier [27]. The
ﬁnal constructs were dissolved in 1mM Tris–HCl—0.1mM EDTA,
pH 8, and a portion was run on 1% agarose gel to assess the amount
of circular DNA.
2.4. Replication and analysis in HEK 293T cells
The HEK293T cells were maintained in Dulbecco’s modi-
ﬁed Eagle’s medium supplemented with 4mM l-glutamine and
adjusted to contain 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, and
10% fetal bovine serum. The cells were grown to ∼90% conﬂuency
and 50ng of each construct was transfected using 6L of Lipo-
fectamine cationic lipid reagent (Invitrogen, Carlsbad, CA). After
transfection with control or lesion containing pMS2, the cells were
grown at 37 ◦C and 5% CO2 for 24h and the plasmid DNA was
collected and puriﬁed by the method of Hirt [28]. Each progeny
DNA was then transformed E. coli DH10B, and the transformants
were analyzed by oligonucleotide hybridization followed by DNA
sequence analysis as described [27].
2.5. TLS assay in human cells
The lesion-containing or control pMS2 construct was mixed in
a 2:1 ratio with a single- stranded pMS2 DNA containing the same
DNA sequence as the construct, except in the 12mer insert it con-
tained a C in place of G two nucleotides 5′ to the lesion site (i.e.,
5′-GTCCGTGTTTGT- 3′). The mutant DNA was used as an internal
control. The mixed DNA was used to transfect HEK293T cells and
processed as described above. Oligonucleotide probes for the com-
plementary sequences for both the lesion containing plasmid and
the internal control plasmid were used to analyze the progeny.
The internal control gave the same number of progeny as the
control construct. Typically, three independent experiments were
performed to determine the extent of TLS with each pol knock-
down.
2.6. Mutational analyses of TLS products from human cells with
pol knockdownsThe procedure described in Section 2.4 was adapted for the
knockdown experiments as follows. Synthetic siRNA duplexes
speciﬁc for TLS pols were transfected into HEK293T cells using
S. Weerasooriya et al. / DNA Repair 35 (2015) 63–70 65
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ipofectamine prior to transfection of the control and lesion con-
aining vectors. HEK293T cells were plated in six-well plates at
0% conﬂuence. After 24h incubation, they were transfected with
00pmol of the siRNA duplex mixed with Lipofectamine, diluted
n Opti-MEM (Gibco), per well. One day before the transfection of
he plasmid, cells were seeded in 24-well plates at 70% conﬂuence.
ells were then co-transfected with another aliquot of siRNA and
ither control or lesion containing plasmid. After 24h incubation
eriod, progeny plasmids were isolated as described earlier.
.7. Reverse transcription polymerase chain reaction (RT-PCR)
nalysis
Total RNA was extracted from the cells 72h after the ﬁrst trans-
ection of siRNA duplexes, using the All Prep DNA/RNA/Protein Kit
Qiagen).Onehundrednanogramsof total RNAwasused forRT-PCR
nalysis, performed with the One Step RT-PCR Kit (Qiagen) accord-
ng to the manufacturer’s instructions. Primer sequences used for
T-PCR are listed in Table S2 of the Supporting information. The
onditions for RT-PCR and siRNAknockdownefﬁciencywere deter-
ined as described elsewhere [29].
. Results
.1. Inhibition of replication by O2-Me-dT and O2-POB-dT
dducts and contribution of pols ,  and Rev1 for lesion bypass
To investigate the mutagenic and replication blocking proper-
ies of the two O2-alkyl-dT adducts formed by the tobacco-speciﬁc
itrosamines, we have constructed ss pMS2 plasmids containing
single O2-Me-dT or O2-POB-dT, and the constructs were repli-
ated in HEK293T cells. Replication of the lesion containing ss
ectors allows for the study of the lesion in the absence of repair,
s ss-plasmids are inefﬁciently repaired by DNA repair pathways.
ig. 1. Effect of siRNA-induced knockdowns of TLS pol(s) on the replicative bypass of O2-
stimated using an internal control of an unmodiﬁed plasmid containing a mutation tw
eviation of results from at least 3 independent experiments (except for the triple kno
ith negative control (NC-si) siRNA whereas the other single knockdowns are as indica
nockdowns were calculated using a two-tailed, unpaired Student’s t test (*p<0.05: **p<e-dT and O2-POB-dT.
However, the mechanism of replication is believed to be similar to
lagging strand synthesis [30].
To determine the roles of individual TLS pols in the bypass of
these two lesions, we employed siRNA knockdown approach to
suppress their expression [31]. In agreementwith previous studies,
the real time PCR and Western blot analysis showed that, for each
pol, the knockdown was at least 70% efﬁcient [29]. Prior to repli-
cation of the lesion containing vectors, HEK293T cell were treated
with siRNA for a speciﬁc TLS pol and allowed 48h to reduce their
expression. A non-speciﬁc siRNA was used as the negative control.
After 48h, another aliquot of siRNAwas added alongwith the lesion
containingvectors, to ensure efﬁcient knockdownof thedesiredpol
during translesion replication.
The relative TLS efﬁciency of the lesion bypass was determined
by a previously reported procedure using an internal control [29].
Brieﬂy, the lesion-containing ss-pMS2 construct was mixed in a
2:1 ratio with another modiﬁed ss-pMS2 plasmid, in which the
12mer insert contained a C instead of G two nucleotides 5’ to the
lesion site and the mixed DNA was transfected into siRNA treated
cells. The unmodiﬁed vectorwas employed as an internal control to
determine the TLS efﬁciency. After transfection, the plasmids were
allowed to replicate for 24h, the progeny plasmids were recov-
ered, transformed to E. coli DH 10B cells, and the resulting colonies
wereanalyzedbyoligonucleotidehybridization [27,29,32]. TLSefﬁ-
ciency for lesion bypass was estimated as the percentage of the
colonies originating from the lesion-containing plasmid relative to
the same from the internal control.
As shown in Fig. 1 (and in Tables S3 & S4 in the Supporting
information), the TLS efﬁciencies of O2-Me-dT and O2-POB-dT in
HEK293T cells transfected with negative control (NC) siRNA were
55% and 26%, respectively, relative to 100%progeny generated from
the control construct. This result is qualitatively similar to what we
have observed in E. coli in that the bulkier O2-POB-dT is a stronger
replication block [22]. In comparison to HEK293T cells that were
treated with NC-siRNA, the TLS efﬁciency for O2-Me-dT decreased
Me-dT and O2-POB-dT in HEK293T cells. The %TLS in various pol knockdowns was
o nucleotides 5’ to the lesion site. The data represent the mean and the standard
ckdown experiments, which were performed twice). HEK293T cells were treated
ted. The statistical signiﬁcance between NC-siRNA treated HEK293T and TLS pols
0.01).
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the effect of simultaneous knockdown of this pol with other bypass
pols. ForO2-Me-dTandO2-POB-dT, simultaneousknockdownofpol
, pol  and Rev1 resulted in 42% and 61% decrease, respectively, inig. 2. Total mutational frequency (MF) of O2-Me-dT and O2-POB-dT in HEK293T ce
he mean and the standard deviation of results from at least 3 independent exper
wice). The statistical signiﬁcance between NC-siRNA treated HEK293T and TLS pol
y 45–53% in pol ,  and Rev1 knockdown cells (Fig. 1). Similarly,
he relative %TLS of O2-POB-dT dropped by 35–46% in pol , pol 
nd Rev1 knockdown cells (Fig. 1). However, knockdown of pol 
r pol  did not show substantial difference in TLS of either lesion
Fig. 1). These results indicate that multiple TLS pols, notably pol ,
ol  andRev1, play important roles in bypassingO2-Me-dT andO2-
OB-dT, albeit none of the pols are indispensable for lesion bypass,
ith the caveat that therewas residual activity of the enzymes even
fter siRNA knockdowns.We also investigated the effects of knock-
own of multiple pols simultaneously. Even when pol , pol  and
ev1were simultaneously knockeddown,which individually had a
ajor effect on the TLS, the additional lowering of TLS was modest.
owever, it is uncertainwhether the remaining lowconcentrations
f the enzymes in the knockdown cells were sufﬁcient to carry out
art of the TLS across the lesions.
.2. Mutational speciﬁcity of O2-Me-dT and O2-POB-dT in
EK293T cells
Fig. 2 shows the DNA sequence analysis results of the TLS
roducts of O2-Me-dT and O2-POB-dT plasmid constructs in the
EK293T cells, which showed that both O2-Me-dT and O2-POB-dT
ere highly mutagenic in human cells. For O2-Me-dT, 64% of the
rogeny analyzed were mutants and only ∼36% progeny yielded
ccurate replication across the lesion in cells transfected with
C siRNA (Fig. 2). Similarly, O2-POB-dT generated ∼53% mutant
rogeny (Fig. 2). Therefore, we conclude that, although O2-POB-
T is a strong block to DNA replication, its replication is 20% more
ccurate relative to O2-Me-dT in human cells. This result is dif-
erent from the result in E. coli, in which O2-POB-dT was found
ore mutagenic than O2-Me-dT [22]. Most mutations in HEK293T
ells were targeted one-base substitutions, while a low frequency
f semi-targetedmutations (i.e.,mutations near the lesion site)was
lso observed (Fig. 3 and Tables S5–S8 in the Supporting informa-
ion). Unlike the most common T→G mutations observed in E. coli
22], the major type of mutations for both O2-Me-dT and O2-POB-
T in HEK293T cells were T→A mutations, detected in 56% and
7% frequency, respectively (Fig. 3). dCMP incorporation opposite
he O2-Me-dT lesion, which leads to T→G mutations at 7% fre-
uency,was the secondmost prevalentmutagenic event; however,
t occurred only at∼2% frequency forO2-POB-dT (Fig. 3). A low level
f T→C (1.5%) and semi-targeted (2.3%) mutations were observed
or O2-POB-dT, but T→C events were not detected in the progeny
rom theO2-Me-dT construct (Fig. 3). It is important to note that no
utationswere detectedwithin the 12mer sequence of the control
onstruct in approximately 300 colonies that were analyzed (data
ot shown).ated with negative control siRNA (NC-si) or siRNA for TLS pol(s). The data represent
s (except for pol  and the triple knockdown experiments, which were performed
kdowns were calculated using two-tailed, unpaired Student’s t test. (*p<0.05).
3.3. Contribution of pols ,  and Rev1 in mutagenesis of
O2-Me-dT and O2-POB-dT
To determine the possible roles of the TLS pols in O2-alkyl-dT
mutagenesis, we analyzed the TLS products obtained from the TLS
pol knockdown cells. MF for O2-Me-dT was reduced in either pol
 or Rev1 knockdown cells by approximately 24–25% relative to
HEK293T cells treated with NC siRNA (Fig. 2). A substantial 44%
reduction in MF was also observed in pol  knockdown cells for
O2-POB-dT, but surprisingly no signiﬁcant change was observed in
Rev1 knockdown cells (Fig. 2). For both O2-Me-dT and O2-POB-dT,
the decrease in MF in different pol knockdown cells was mainly
due to a reduction in T→A mutations (Fig. 3). For both O2-POB-
dT and O2-Me-dT, knockdown of pol , pol , or pol  resulted in
little changes in MF (Fig. 2). Since knockdown of pol  exhibited
a substantial reduction in MF for both lesions, we have exploredFig. 3. Types of mutations observed in HEK293T cells treated with NC siRNA (NC-si)
or siRNA for individual TLS pol(s). The data represent the mean and the standard
deviation of results from at least 3 independent experiments (except for pol  and
the triple knockdown experiments, which were performed twice).
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F (Fig. 2). Simultaneousknockdownofpol, pol  andpol, on the
ther hand, reduced MF of O2-Me-dT and O2-POB-dT, respectively,
y 40% and 54% (Fig. 2).
. Discussion
.1. Involvement of pol ,  and Rev1 for bypass of O2-Me-dT and
2-POB-dT
It is well established that NNK, a tobacco speciﬁc nitrosamine, is
potent carcinogen in experimental animals andhumans [4,33,34].
uring metabolic activation of NNK, multiple reactive intermedi-
tes are generated that react with DNA, forming adducts, which
re presumed to play a role in chemical carcinogenesis [8]. In this
tudywe focusedon the replicationproperties ofO2-Me-dT andO2-
OB-dT. O2-POB-dT is the most abundant bulky adduct in human
ells formed during metabolic activation of NNK. While O2-Me-dT
as not been identiﬁed in NNK-treated animals, small amounts are
ndoubtedly formed, based upon the chemistry of the methylation
athway. In our study, O2-Me-dT serves as a model to dissect the
elative importance of the altered Watson-Crick hydrogen bond-
ng and bulkiness of O2-POB-dT. The TLS efﬁciency for O2-Me-dT
nd O2-POB-dT in NC-siRNA treated HEK293T cells were 55% and
6%, respectively (Fig. 1). This is an order of magnitude higher than
.5% and 2.7%, respectively, TLS of O2-Me-dT and O2-POB-dT in
ninduced E. coli, which increase only 2–4-fold upon induction of
OS [22]. Comparable magnitude of increase in TLS efﬁciency in
uman cells compared to E. coli has been reported in TLS of the
basic site [35,36]. It is conceivable that TLS efﬁciency for most
eplication-blocking DNA lesions is greater in human cells than in
. coli, presumablydue toanabundanceofbypasspols in the former.
urthermore, as in E. coli, the bulkier O2-POB-dT was more geno-
oxic and bypassed less efﬁciently in human cells than O2-Me-dT.
n another study in E. coli, it was established that the TLS efﬁciency
ecreases with longer chain lengths of O2-alkyldT [23], which is
onsistent with the results of our current study.
The TLS efﬁciency for O2-Me-dT in pol , pol  or Rev1 knock-
own cells decreased by approximately 45–53%, whereas for
2-POB-dT it was decreased by 35–46% (Fig. 1). This indicates
nvolvement of multiple TLS pols for the lesion bypass, which sup-
orts the current hypothesis that more than one pol and multiple
ol switches are involved during the TLS process [37–40]. The TLS
fﬁciency dropped by 45% and 35%, respectively, for O2-Me-dT and
2-POB-dT in pol  knockdown cells (Fig. 1). Pol  is considered one
f the main pols that performs TLS of many lesions due to its capa-
ious catalytic site [41–43]. Reduced TLS efﬁciency for both lesions
n pol  knockdown cells indicates involvement of this pol in the
esion bypass. This is comparable to what we observed in E. coli,
hat is pol V, the ortholog of pol , is essential for bypass of these
esions [22,44].
We have established that pol  is critical for TLS of both O2-
e-dT and O2-POB-dT since the TLS efﬁciency was reduced in pol 
nockdowncells by45%and42%, respectively (Fig. 1). Pol hasbeen
eported to perform extension after incorporation of a nucleotide
pposite a lesion during TLS [45]. Therefore, it is conceivable that,
t could function efﬁciently in the extension of the nucleotides thatonated O2-alkyl-dT:dA, (c) protonated O2-alkyl-dT:dT, and (d) O2-alkyl-dT:dG.
were preferentially incorporated by pol  and by pol  or pol .
Likewise, Rev1 is equally important for O2-Me-dT and O2-POB-dT
bypass, as shown by 46–53% reduction in TLS in Rev1 knockdown
cells. Based on experimental evidences it is accepted that Rev1
functionally interact with all other Y family pols during TLS pro-
cess [46–48]. Therefore, it is likely that Rev1 acts as a structural
element to form a bridge between the inserter, speciﬁcally pol ,
and the extender, pol , during TLS of O2-Me-dT and O2-POB-dT.
However, when both pol  and pol  together with either pol 
or Rev1 were simultaneously knocked down, further reduction in
TLS efﬁciency was modest. This suggests that, upon knockdown of
these critical pols, part of TLS (∼40%) may still be carried out by
other TLS pols and the remaining fraction of these pols that was
not knocked down.
4.2. Mutagenicity of O2-Me-dT and O2-POB-dT and error-prone
bypass by the TLS pols
Analysis of the progeny showed that both O2-Me-dT and O2-
POB-dT are highly mutagenic lesions in HEK293T cells with MF
of 65% and 53%, respectively (Fig. 2). The relative MF of these
two lesions was essentially reversed from what was reported in
SOS-induced E. coli cells, where MF was found to be 21% and 56%
for O2-Me-dT and O2-POB-dT, respectively [22]. In HEK293T cells,
although bulkier O2-POB-dT was a stronger replication block, as
reported in bacteria, it was bypassed slightlymore accurately com-
pared to O2-Me-dT. We suspect that, owing to the small size of the
alkyl chain of the O2-Me-dT, it can be easily accommodated in the
capacious catalytic site of the TLS pols, resulting in more efﬁcient
replication, albeit with low ﬁdelity [49]. Even a relatively small
methyl groupat the2positionof thymidine interfereswith thebase
pairingmodeswith A and, based on thermalmelting studies, Gwas
found to be a better partner thanA [50]. However, rather than T→C
mutation, as suggested by the thermal melting experiments, the
major type ofmutations induced by bothO2-Me-dT andO2-POB-dT
wasT→Atransversions, at a frequencyof56%and47%, respectively
(Fig. 3). The second most prevalent mutagenic event for O2-Me-dT
was T→G (7%) followed by low levels of semi-targeted mutations
(0.9%). O2-POB-dT generated approximately the same frequency
of T→G, T→C and the semi-targeted mutations, which ranged
from 1.5 to 2.3% (Fig. 3). In NNK treated mice, AT→TA mutations
occurred 2 to 3 times more frequently than AT→CG or AT→GC
mutations [13,51]. Furthermore, in vitrokinetic studies showed that
dTTP incorporation opposite O2-POB-dT was more efﬁcient than
either dCTP or dGTP incorporation by both E. coli Kf− and Sulfolobus
solfataricus DNA pol IV (Dpo4), two model DNA pols [25]. Our cel-
lular results for O2-POB-dT are in agreement with the mutational
spectra obtained from NNK-treated rodents as well as the in vitro
kinetic data by puriﬁed model pols. In vitro replication study on
a template containing O2-Me-dT, in a different sequence context,
showed that it is a strong block of DNA replication by E. coli DNA
polymerase I (Kf−), yeast pol , and human pol  [24]. However, Kf−and yeast pol  preferentially incorporated the correct nucleotide,
dAMP,while human pol  preferred dCMP oppositeO2-Me-dT [24].
Fromour study, however, thegreatest reduction inT→Gmutations
occurred when either pol  or pol  was knocked down (Fig. 3). Yet,
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henpol  aswell as twoother TLS polswere knockeddown simul-
aneously, T→G mutations remain unaffected. This suggests that a
art of T→G mutations stems from dCMP incorporation opposite
2-Me-dT by pol , but the mismatched pair can be extended either
y pol  or another TLS pol.
The targeted T→A events changed in different pol knockdown
ells for both O2-Me-dT and O2-POB-dT. Nevertheless, the pattern
f the mutations remained comparable in most knockdown cells
Fig.3). Although theTLSefﬁciencywas reduced inpolknockdown
ells, the MF was only slightly reduced for both lesions, suggest-
ng that both error-free and erroneous TLS are catalyzed by pol .
ol  was found to be involved in error-prone bypass of different
NA lesions [43], whereas it conducts accurate and efﬁcient TLS
f 7,8-dihydro-8-oxoguanine and cis-syn thymine-thymine dimer
52–54]. It is possible that it is involved in both correct nucleotide
ncorporation of dAMP and misincorporation of dTMP opposite
oth O2-alkyl-dT lesions. But pol  and pol  may also be involved
n misincorporation opposite these lesions. As a result, it is chal-
enging at this time to distinguish the roles of each TLS pol, as
esidual 10–30% enzyme may be able to carry out TLS across the
esions in the knockdown experiments. Future experiments prefer-
bly using a combination of in vitro assay and knockout cell lines
ill be needed to distinguish the roles of individual pol in the lesion
ypass.
In pol  knockdown cells, the MF for O2-Me-dT and O2-POB-dT
as decreased by 25% and 44%, respectively, in addition to a reduc-
ion in TLS efﬁciency (Fig. 2). Pol  is relatively tolerant of abnormal
tructure at the primer terminus [55,56]. Hence, we postulate that
t takes a more active role in the extension of O2-alkyl-dT:dT mis-
atchedbasepair in comparison to the correctO2-alkyl-dT:dApair,
eading to error-prone replication of both lesions. The extension of
2-alkyl-dT:dTmismatchbypol  appeared tobemorepronounced
n the TLS of bulkierO2-POB-dT, presumably because the extension
f the correct O2-POB-dT:A pair was even more inefﬁcient (Fig. 3).
he MF in Rev1 knockdown cells was reduced to a similar extent as
n pol  knockdown cells for O2-Me-dT, indicating that Rev1 plays
n indispensable structural role in pol  dependent bypass of O2-
e-dT (Fig. 2). It is unclear why it does not play a similar role in
2-POB-dT bypass, since MF of O2-POB-dT remained unaltered in
ev1 knockdown cells.
.3. Mechanistic rationale for the error-prone TLS of O2-alkyl-dT
The mechanistic rationale for the preferential insertion of dT
nd dA opposite O2-alkyl-dT is not clear. The ability to form
atson–Crick-like structures has been proposed to explain the
utagenic potential of DNA adducts. This analysis worked well
ith O6-methylguanine, in which the Watson–Crick-like structure
n Fig. 4a, initially proposed by Loveless in 1969 [57], explains the
utagenic incorporation of dTTP [58–60]. However, the attempt to
uplicate this analysis with O2-alkyl-dT is not as satisfying. Fig. 4b
hows a Watson–Crick-like structure between dA and O2-alkyl-dT.
hile the structure requires protonation, the alkyl group can also
ake a hydrophobic interaction with the 2-position of adenine
tabilizing the structure [61]. Fig. 4c displays a base-pair struc-
ure between dT and O2-alkyl-dT similar to the wobble structure
hat was observed in an oligodeoxynucleotide duplex containing a
T/dT mispair [62]. Evidently, this structure is not Watson–Crick-
ike. There are no noticeable features of Fig. 4b and c that would
xplain why dA and dT are inserted opposite O2-alkyl-dT more
ften than dG in the absence of any structural studies. Fig. 4d shows
potential Watson–Crick-like structure between dG and O2-alkyl-
T. This structure is very similar to Fig. 4a, except that the alkyl
roup is in the minor groove. Perhaps this structure explains the
utagenic incorporation of dGTP opposite O2-alkyl-dT by pol V in
. coli [22,63]. However, the preference for the incorporation of dT
[epair 35 (2015) 63–70
and dA opposite O2-alkyl-dG in humans cells is not evident. The
different speciﬁcities in different kingdoms indicate that protein-
DNA interactions play a large role in determining the identity of the
nucleotide inserted opposite O2-alkyl-dTs.
5. Conclusion
In conclusion, the O2-Me-dT and O2-POB-dT formed by the
tobacco-speciﬁc nitrosamines were found to be strong blocks of
DNA replication and highlymutagenic in HEK293T cells. This result
is consistent with the POB-pathway playing an important role in
NNK carcinogenesis. While the bulkier O2-POB-dT was a stronger
replicationblock compared toO2-Me-dT, the latterwasmoremuta-
genic. The major type of mutations induced by these lesions was
T→A, but low frequencies of T→G, T→C, and semi-targeted
mutations also were detected. Though pols ,  and Rev1 play
important roles in the error-prone replication of these lesions,
siRNA knockdown experiments showed that pol  is a key enzyme
for mutagenesis induced by O2-POB-dT.
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